Results
|
|
14261.
|
|
|
|
14262.
|
|
|
|
14263.
|
|
|
|
14264.
|
|
|
|
14265.
|
|
|
|
14266.
|
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer. [electronic resource] by
- Sculier, J P
- Lafitte, J J
- Lecomte, J
- Berghmans, T
- Thiriaux, J
- Van Cutsem, O
- Efremidis, A
- Ninane, V
- Paesmans, M
- Mommen, P
- Klastersky, J
Producer: 20021204
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 13
Availability: No items available.
|
|
|
14267.
|
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. [electronic resource] by
- Tsimberidou, Apostolia M
- McLaughlin, Peter
- Younes, Anas
- Rodriguez, Maria A
- Hagemeister, Fredrick B
- Sarris, Andreas
- Romaguera, Jorge
- Hess, Mark
- Smith, Terry L
- Yang, Ying
- Ayala, Ana
- Preti, Alejandro
- Lee, Ming-Sheng
- Cabanillas, Fernando
Producer: 20030128
In:
Blood vol. 100
Availability: No items available.
|
|
|
14268.
|
|
|
|
14269.
|
|
|
|
14270.
|
|
|
|
14271.
|
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study. [electronic resource] by
- Christodolou, C
- Pavlidis, N
- Samantas, E
- Fountzilas, G
- Kouvatseas, G
- Pagdatoglou, K
- Palamidas, F
- Nikolaidis, C
- Angelidou, M
- Kalofonos, H P
- Kosmidis, P
- Skarlos, D V
Producer: 20030224
In:
Anticancer research vol. 22
Availability: No items available.
|
|
|
14272.
|
|
|
|
14273.
|
|
|
|
14274.
|
|
|
|
14275.
|
Expression of wild-type p53 gene confers increased sensitivity to radiation and chemotherapeutic agents in human esophageal carcinoma cells. [electronic resource] by
- Matsubara, H
- Kimura, M
- Sugaya, M
- Koide, Y
- Gunji, Y
- Takegana, K
- Asano, T
- Ochiai, T
- Isono, K
- Sakiyama, S
- Tagawa, M
Producer: 19990629
In:
International journal of oncology vol. 14
Availability: No items available.
|
|
|
14276.
|
|
|
|
14277.
|
|
|
|
14278.
|
|
|
|
14279.
|
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma. [electronic resource] by
- Costa, S
- Terzano, P
- Bovicelli, A
- Martoni, A
- Angelelli, B
- Santini, D
- Ceccarelli, C
- Lipponen, P
- Erzén, M
- Syrjänen, S
- Syrjänen, K
Producer: 20010201
In:
Gynecologic oncology vol. 80
Availability: No items available.
|
|
|
14280.
|
|